Previous Article | Next Article ![]()
Journal of Clinical Microbiology, July 2004, p. 3329-3332, Vol. 42, No. 7
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.7.3329-3332.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Pathology, National Cheng Kung University Hospital,1 Departments of Pathology,2 Internal Medicine,3 Medical Technology, College of Medicine, National Cheng Kung University, Tainan, Taiwan4
Received 2 October 2003/ Returned for modification 17 December 2003/ Accepted 22 March 2004
In an epidemiologic and case-control study including 30 case patients over a 3.5-year period in a Taiwanese university hospital, only ß-lactamase inhibitor use and extended-spectrum cephalosporin use were identified as independent risk factors for nosocomial CMY-2-producing Escherichia coli bloodstream infection, and CMY-2 producers were found more prevalent than extended-spectrum ß-lactamase-producing isolates.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»